Anna Kushnir, PhD

Anna Kushnir, PhD

Senior Vice President for Preclinical Development, Vaccines

Dr. Kushnir serves as the conduit between the preclinical, regulatory and clinical functions of Codagenix, and manages preclinical R&D at contract facilities. Prior to joining Codagenix, Dr. Kushnir started and grew a thriving life sciences practice within a federal marketing and appropriations firm. She supported industry and academic clients in securing federal funding for R&D and in shaping an R&D strategy to minimize time and money required to reach the commercial market. Dr. Kushnir holds a BA in Biology from the University of Virginia and a PhD in Virology from Harvard University.

Back to Anna Kushnir, PhD